Contact MENU

News

Showing posts for — Category: Press Releases

05.08.19

EyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business Update

WALTHAM, MA, May 8, 2019 – EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the quarter ended March 31, 2019 and provided an update...
Read more
05.02.19

EyeGate Files IDE with FDA for PRK Pivotal Study

WALTHAM, Mass., May 2, 2019 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) announced today it has successfully submitted the Investigational Device Exemption (“IDE”) to the U.S....
Read more
03.26.19

EyeGate Confirms Path to De Novo Filing with FDA

WALTHAM, MA / ACCESSWIRE / March 26, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") has met with the U.S. Food and Drug Administration ("FDA") regarding its Ocular...
Read more
03.04.19

EyeGate Pharmaceuticals Reports Full Year 2018 Financial Results and Provides Business Update

WALTHAM, MA / ACCESSWIRE / March 1, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (''EyeGate'' or ''the Company'') today announced financial results for the year ended December 31, 2018 and provided...
Read more
01.29.19

EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City

WALTHAM, Mass., January 29, 2019 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced that the Company will attend and present at the 21st BIO...
Read more
01.16.19

EyeGate Pharmaceuticals Announces Meeting Date with FDA

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today confirmed that it is scheduled to meet with the U.S. Food and...
Read more
11.13.18

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period ended September 30, 2018 and...
Read more
11.13.18

EyeGate Pharma Announces Positive Results in Punctate Epitheliopathy Study

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating the potential of EyeGate’s Ocular Bandage Gel (OBG) to...
Read more

Stay up to date with the latest company news

Sign Up